Entities / Company
Arcellx.
Biotechnology Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 25
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Arcellx received FDA clearance for its IND application and plans a commercial launch in the US.Some support1 report
-
Arcellx underperformed the S&P 500 market so far this year.Some support1 report
-
Gilead Sciences expanded a partnership to co-develop next-generation CAR-T cell therapies.Some support1 report
-
Arcellx participated in a conference in September 2025 involving Morgan Stanley.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
Around Arcellx this week
News at the entities that move Arcellx most-
Milan Shared contextAffordability protests have spread from Paris and Milan to Lisbon, and have also gripped Albania.Moves Arcellx
-
Gilead Sciences StructuralBenzinga generated content regarding the financial performance of Gilead Sciences on June 17, 2026.Moves Arcellx
Connections
The 3 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Gilead Sciences Structural
Arcellx was acquired by Gilead Sciences in a definitive transaction to integrate its technology into Gilead's portfolio.
-
Rami Elghandour Structural
Rami Elghandour serves as the CEO of Arcellx.
-
Milan Shared context
Arcellx conducts professional events and presentations within the city of Milan.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
4 events- Arcellx received FDA clearance for its IND application and plans a commercial launch in the US.
- Arcellx underperformed the S&P 500 market so far this year.
- Gilead Sciences expanded a partnership to co-develop next-generation CAR-T cell therapies.
- Arcellx participated in a conference in September 2025 involving Morgan Stanley.